HCV seroconversion among never-injecting heroin users at baseline: No predictors identified other than starting injection

International Journal of Drug Policy

Volumn 23, Issue 5, 2012, Pages 415-419

  Bravo, María J ^a,b   Vallejo, Fernando ^a,b   Barrio, Gregorio ^b,c   Brugal, M Teresa ^b,d,e   Molist, Gemma ^a,b   Pulido, José ^a,b   Sordo, Luis ^a,b   de la Fuente, Luis ^a,b  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^e BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

Author keywords

Drug injection; HCV incidence; HCV risk factors; Heroin users

Indexed keywords

COCAINE; DIAMORPHINE;

ADULT; ARTICLE; BLOOD ANALYSIS; COCAINE DEPENDENCE; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FOLLOW UP; HEPATITIS C; HEROIN DEPENDENCE; HIGH RISK BEHAVIOR; HUMAN; INCIDENCE; INFECTION RISK; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; SEXUAL BEHAVIOR; SPANISH;

ADOLESCENT; ADULT; COHORT STUDIES; DATA COLLECTION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HEROIN DEPENDENCE; HUMANS; MALE; MULTIVARIATE ANALYSIS; POISSON DISTRIBUTION; PROSPECTIVE STUDIES; RISK; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84866175677     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2012.02.002     Document Type: Article

References (15)

1. Aaron S., McMahon J.M., Milano D., Torres L., Clatts M., Tortu S., et al. Intranasal transmission of hepatitis C virus: Virological and clinical evidence. Clinical Infectious Diseases 2008, 47:931-934.
2. Barrio G., de la Fuente L., Royuela L., Diaz A., Rodriguez-Artalejo F. Cocaine use among heroin users in Spain: The diffusion of crack and cocaine smoking Spanish Group for the Study on the Route of Administration of Drugs. Journal of Epidemiology and Community Health 1998, 52:172-180.
3. Conry-Cantilena C., VanRaden M., Gibble J., Melpolder J., Shakil A.O., Viladomiu L., et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. New England Journal of Medicine 1996, 334:1691-1696.
4. de la Fuente L., Brugal M.T., Ballesta R., Barrio G., Bravo M.J., Domingo-Salvany A., et al. Metodología del estudio de cohortes del proyecto Itínere sobre consumidores de heroína en tres ciudades españolas y características básicas de los participantes. Revista Espanola De Salud Publica 2005, 79:475-491.
5. Des Jarlais D.C., Arasteh K., Perlis T., Hagan H., bdul-Quader A., Heckathorn D.D., et al. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS 2007, 21:231-235.
6. EMCDDA The State of Drug Use Problem in Europe Annual Report 2010 2010, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Luxembourg.
7. Fuller C.M., Ompad D.C., Galea S., Wu Y., Koblin B., Vlahov D. Hepatitis C incidence-A comparison between injection and noninjection drug users in New York City. Journal of Urban Health 2004, 81:20-24.
8. Gyarmathy V.A., Neaigus A., Miller M., Friedman S.R., Des Jarlais D.C. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. Journal of Acquired Immune Deficiency Syndromes 2002, 30:448-456.
9. Howe C.J., Fuller C.M., Ompad D.C., Galea S., Koblin B., Thomas D., et al. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug and Alcohol Dependence 2005, 79:389-395.
10. Judd A., Hickman M., Rhodes T. Transmission of hepatitis C-Are noninjecting cocaine users at risk?. Substance Use & Misuse 2002, 37:573-575.
11. Neaigus A., Gyarmathy V.A., Zhao M., Miller M., Friedman S.R., Des Jarlais D.C. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users. Journal of Infectious Diseases 2007, 195:1052-1061.
12. Roy E., Haley N., Leclerc P., Boivin J.F., Cedras L., Vincelette J. Risk factors for hepatitis C virus infection among street youths. CMAJ 2001, 165:557-560.
13. Scheinmann R., Hagan H., Lelutiu-Weinberger C., Stern R., Des Jarlais D.C., Flom P.L., et al. Non-injection drug use and hepatitis C virus: A systematic review. Drug and Alcohol Dependence 2007, 89:1-12.
14. Tuaillon E., Mondain A.M., Meroueh F., Ottomani L., Picot M.C., Nagot N., et al. Dried blood spot for hepatitis C virus serology and molecular testing. Hepatology 2010, 51:752-758.
15. van den Berg C.H., van de Laar T.J., Kok A., Zuure F.R., Coutinho R.A., Prins M. Never injected, but hepatitis C virus-infected: A study among self-declared never-injecting drug users from the Amsterdam Cohort Studies. Journal of Viral Hepatitis 2009, 16:568-577.